Robert Papp
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Analytical Methods in Pharmaceuticals 4
- Analytical chemistry methods development 2
- Oncology 6
- PARP inhibition in cancer therapy 4
- Co-authors
- Markus Kellmann (1 shared paper)Kevin P. Bateman (1 shared paper)Helmut Muenster (1 shared paper)Elizabeth C. Kwong (4 shared papers)Wayne M. Mullett (4 shared papers)Richard A. Tschirret-Guth (2 shared papers)Dieter Lubda (1 shared paper)Louis‐David Cantin (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)Molecular Cancer Therapeutics (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Chromatography B (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Robert Papp
18 papers receiving 734 citations
Robert Papp's Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 226
- Analytical Chemistry 99
- Spectroscopy 107
- Molecular Biology 336
- Toxicology 22
Countries citing papers authored by Robert Papp
This map shows the geographic impact of Robert Papp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Papp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Papp more than expected).
Fields of papers citing papers by Robert Papp
This network shows the impact of papers produced by Robert Papp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Papp. The network helps show where Robert Papp may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Papp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition Hit paper breakdown → | 2022 | 177 |
| 2 | 2009 | 148 | |
| 3 | 2021 | 83 | |
| 4 | 2021 | 69 | |
| 5 | 2022 | 58 | |
| 6 | 2022 | 52 | |
| 7 | 2005 | 29 | |
| 8 | 2007 | 29 | |
| 9 | 2024 | 23 | |
| 10 | Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis). | 2010 | 21 |
| 11 | 2004 | 20 | |
| 12 | 2010 | 20 | |
| 13 | 2024 | 15 | |
| 14 | 2013 | 13 | |
| 15 | 2011 | 9 | |
| 16 | 2025 | 9 | |
| 17 | 2025 | 8 | |
| 18 | 2007 | 2 | |
| 19 | 2024 | 0 |
About Robert Papp
Robert Papp is a scholar working on Analytical Chemistry, Oncology, Spectroscopy, Pharmaceutical Science and Pharmacology, having authored 19 papers that have together received 785 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (4 papers), PARP inhibition in cancer therapy (4 papers), Analytical Chemistry and Chromatography (3 papers), Synthesis and biological activity (3 papers), Drug Solubulity and Delivery Systems (2 papers), Microtubule and mitosis dynamics (2 papers), Analytical chemistry methods development (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Oncology (226 citations), Analytical Chemistry (99 citations), Spectroscopy (107 citations), Molecular Biology (336 citations) and Toxicology (22 citations). Robert Papp has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Markus Kellmann, Kevin P. Bateman, Helmut Muenster, Elizabeth C. Kwong, Wayne M. Mullett, Richard A. Tschirret-Guth, Dieter Lubda, Louis‐David Cantin, Susana Liu and Donald W. Nicholson. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical and Biomedical Analysis, Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry Letters and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.